Now available: SPIDIA4P Newsletter – November 2022
Read about news on in vitro diagnostics and stay up to date on ISO standards, CEN Technical Specifications, the External Quality Assurance (EQA) programme and activities SPIDIA4P.
The H2020 project SPIDIA4P has officially reached the end of the funding period. However, the SPIDIA consortium – of which BBMRI.at partner Med Uni Graz and also BBMRI-ERIC are members – will continue their mission.
They will go on to develop and implement European and international standards for pre-analytical workflows for in vitro diagnostics, biobanking and medical research and continue to offer courses to these quality management issues.
Such ISO standards under development are for example:
- ISO/TS 18701 (ersetzt: CEN/TS 17626) Molecular in vitro diagnostic examinations – Specifications for pre-examination processes for human specimens – Isolated microbiome DNA
- ISO/18703 (ersetzt: CEN/TS 17742) Molecular in vitro diagnostic examinations – Specifications for pre-examination processes for venous whole blood – Isolated circulating cell free RNA from plasma
- ISO/TS 18702 (ersetzt: CEN/TS 17747) Molecular in vitro diagnostic examinations – Specifications for pre-examination processes for exosomes and other extracellular vesicles in venous whole blood – DNA, RNA and proteins
- ISO/18704 (ersetzt: CEN/TS 17811) Molecular in vitro diagnostic examinations – Specifications for pre-examination processes for urine and other body fluids – Isolated cell free DNA – CEN/TS 17811.
By using these and other standards, you ensure your results and diagnoses are reliable and reproducible. In turn, this contributes to better diagnostics and healthcare for everyone.
